BATS BZX Real-Time Price
As of 12:16pm ET
| +0.02 / +1.42%|
The 6 analysts offering 12-month price forecasts for Cardiome Pharma Corp have a median target of 5.45, with a high estimate of 9.50 and a low estimate of 2.80. The median estimate represents a +281.12% increase from the last price of 1.43.
The current consensus among 6 polled investment analysts is to Buy stock in Cardiome Pharma Corp. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.